Bowel cancer is the second leading cause of death in the western world after cardiovascular disease. Among the different types of tumors, bowel cancer is the most frequently occurring in the adult population, considering both genders.
CerTest FOB Turbilatex is a non-invasive immunological test which can be used in a simple and effective manner in bowel cancer screening.
Colonic lesions considered preneoplastic (polyps) and invasive new vessel growth may bleed, even in the early stages of their development. Consequently, fecal occult blood tests (FOBT) are able to offer clinical evidence for the early diagnosis of bowel cancer in its different stages or states.
The FOB Turbilatex reagents detect and quantify human hemoglobin, a protein present in blood which may be found in low concentration in patients’ feces.
This protein is sensitive to degradation in the gastrointestinal system, and therefore its use is limited to the detection of bleeding from the colon.